Iván J. Suñer

3.7k total citations · 1 hit paper
36 papers, 2.0k citations indexed

About

Iván J. Suñer is a scholar working on Ophthalmology, Radiology, Nuclear Medicine and Imaging and Molecular Biology. According to data from OpenAlex, Iván J. Suñer has authored 36 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Ophthalmology, 21 papers in Radiology, Nuclear Medicine and Imaging and 4 papers in Molecular Biology. Recurrent topics in Iván J. Suñer's work include Retinal Diseases and Treatments (29 papers), Retinal Imaging and Analysis (16 papers) and Retinal and Optic Conditions (15 papers). Iván J. Suñer is often cited by papers focused on Retinal Diseases and Treatments (29 papers), Retinal Imaging and Analysis (16 papers) and Retinal and Optic Conditions (15 papers). Iván J. Suñer collaborates with scholars based in United States, Australia and Italy. Iván J. Suñer's co-authors include Scott W. Cousins, Diego G. Espinosa‐Heidmann, Eleut P. Hernandez, Roman G. Rubio, Karl G. Csaky, Chantal Dolan, Neil M. Bressler, Dagoberto Monroy, David M. Brown and Jeffrey S. Heier and has published in prestigious journals such as Ophthalmology, American Journal of Ophthalmology and Investigative Ophthalmology & Visual Science.

In The Last Decade

Iván J. Suñer

33 papers receiving 1.9k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Twelve-Month Efficacy and Safety of 0.5 mg or 2.0 mg Ranibizumab in Patients with Subfoveal Neovascular Age-related Macular Degeneration

2013 407 citations Brandon Busbee, Allen C. Ho et al. Ophthalmology profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author						Papers	Cites
Iván J. Suñer	1.8k	1.1k	354	149	127	36	2.0k
Saleh A. Al‐Obeidan	1.3k 0.7×	458 0.4×	234 0.7×	116 0.8×	80 0.6×	84	1.5k
Philipp S. Muether	1.3k 0.7×	1.1k 1.0×	296 0.8×	109 0.7×	42 0.3×	55	1.7k
Katherine E. Talcott	992 0.6×	678 0.6×	381 1.1×	172 1.2×	43 0.3×	114	1.6k
Sandrine Zweifel	2.4k 1.3×	1.7k 1.5×	551 1.6×	147 1.0×	43 0.3×	121	2.7k
V. Diana	2.1k 1.2×	1.5k 1.3×	472 1.3×	116 0.8×	32 0.3×	69	2.5k
I H Chisholm	2.4k 1.3×	1.7k 1.5×	506 1.4×	220 1.5×	43 0.3×	20	2.6k
Luís Arias	2.0k 1.1×	1.4k 1.2×	391 1.1×	208 1.4×	54 0.4×	119	2.2k
Rosa Dolz‐Marco	2.8k 1.5×	1.8k 1.6×	547 1.5×	156 1.0×	44 0.3×	155	3.1k
Bora Eldem	1.4k 0.8×	883 0.8×	183 0.5×	100 0.7×	37 0.3×	54	1.6k
Zhongming Yang	1.2k 0.7×	838 0.7×	193 0.5×	43 0.3×	89 0.7×	23	1.5k

Countries citing papers authored by Iván J. Suñer

Since Specialization

Citations

This map shows the geographic impact of Iván J. Suñer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Iván J. Suñer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Iván J. Suñer more than expected).

Fields of papers citing papers by Iván J. Suñer

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Iván J. Suñer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Iván J. Suñer. The network helps show where Iván J. Suñer may publish in the future.

Co-authorship network of co-authors of Iván J. Suñer

This figure shows the co-authorship network connecting the top 25 collaborators of Iván J. Suñer. A scholar is included among the top collaborators of Iván J. Suñer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Iván J. Suñer. Iván J. Suñer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Ali, Ferhina S., Sruthi Arepalli, Durga S. Borkar, et al.. (2025). Coring of Intravitreal Medication Vial Stoppers: A Report From the Research and Safety in Therapeutics Committee of the American Society of Retina Specialists. Journal of VitreoRetinal Diseases. 9(5). 546–549.

Kolomeyer, Anton M., David Eichenbaum, Daniel F. Kiernan, Iván J. Suñer, & Seenu M. Hariprasad. (2023). The 0.19-mg Fluocinolone Acetonide Implant for the Treatment of Diabetic Macular Edema: An Expert Consensus. Ophthalmic surgery, lasers & imaging retina. 54(3). 166–173. 2 indexed citations

Diana, V., Carmelina Gordon, Iván J. Suñer, et al.. (2022). Proliferative Diabetic Retinopathy Events in Patients With Diabetic Macular Edema: Post Hoc Analysis of VISTA and VIVID Trials. Journal of VitreoRetinal Diseases. 6(4). 295–301. 2 indexed citations

Suñer, Iván J. & Marc C. Peden. (2021). Dexamethasone Sustained-Release Intracanalicular Insert for Control of Postoperative Inflammation After Pars Plana Vitrectomy. Clinical ophthalmology. Volume 15. 3859–3864. 10 indexed citations

Varma, Rohit, Neil M. Bressler, Quan V. Doan, et al.. (2020). <p>Diabetic Population-Based Model to Estimate Impact of Ranibizumab on Diabetic Retinopathy Severity in Patients with Diabetic Macular Edema</p>. Clinical ophthalmology. Volume 14. 1249–1259. 1 indexed citations

Peden, Marc C., et al.. (2020). Brolucizumab-related retinal vasculitis with exacerbation following ranibizumab retreatment: A clinicopathologic case study. American Journal of Ophthalmology Case Reports. 20. 100989–100989. 42 indexed citations

Sivaprasad, Sobha, Iván J. Suñer, Robyn H. Guymer, et al.. (2017). Content validity of the NEI VFQ-25 in patients with geographic atrophy. Investigative Ophthalmology & Visual Science. 58(8). 3214–3214. 1 indexed citations

Suñer, Iván J., Neil M. Bressler, Rohit Varma, et al.. (2016). RESPONSIVENESS OF THE NATIONAL EYE INSTITUTE VISUAL FUNCTION QUESTIONNAIRE-25 TO VISUAL ACUITY GAINS IN PATIENTS WITH DIABETIC MACULAR EDEMA. Retina. 37(6). 1126–1133. 12 indexed citations

Suñer, Iván J., Marc C. Peden, Mark E. Hammer, et al.. (2014). RaScaL: A Pilot Study to Assess the Efficacy, Durability, and Safety of a Single Intervention with Ranibizumab plus Peripheral Laser for Diabetic Macular Edema Associated with Peripheral Nonperfusion on Ultrawide-Field Fluorescein Angiography. Ophthalmologica. 233(2). 89–95. 9 indexed citations

10.

Busbee, Brandon, Allen C. Ho, David M. Brown, et al.. (2013). Twelve-Month Efficacy and Safety of 0.5 mg or 2.0 mg Ranibizumab in Patients with Subfoveal Neovascular Age-related Macular Degeneration. Ophthalmology. 120(5). 1046–1056. 407 indexed citations breakdown →

11.

Suñer, Iván J., et al.. (2012). HARBOR Study: One-Year Results of Efficacy and Safety of 2.0 mg versus 0.5 mg Ranibizumab in Patients with Subfoveal Choroidal Neovascularization Secondary to Age-Related Macular Degeneration. Investigative Ophthalmology & Visual Science. 53(14). 3677–3677. 4 indexed citations

12.

Varma, Rohit, Neil M. Bressler, Iván J. Suñer, et al.. (2012). Improved Vision-Related Function after Ranibizumab for Macular Edema after Retinal Vein Occlusion. Ophthalmology. 119(10). 2108–2118. 126 indexed citations

13.

Bressler, Neil M., Quan V. Doan, Rohit Varma, et al.. (2011). Estimated Cases of Legal Blindness and Visual Impairment Avoided Using Ranibizumab for Choroidal Neovascularization. Archives of Ophthalmology. 129(6). 709–17. 93 indexed citations

14.

Varma, Rohit, Neil M. Bressler, Iván J. Suñer, et al.. (2010). Ranibizumab Improves Patient-Reported Near and Distance Vision Activities in Patients With Macular Edema Following Retinal Vein Occlusion. Investigative Ophthalmology & Visual Science. 51(13). 5212–5212. 1 indexed citations

15.

Bressler, Neil M., Tom Chang, Iván J. Suñer, et al.. (2010). Vision-Related Function after Ranibizumab Treatment by Better- or Worse-Seeing Eye. Ophthalmology. 117(4). 747–756.e4. 111 indexed citations

16.

Friberg, Thomas R., et al.. (2008). Ultrawide Angle Fluorescein Angiographic Imaging: A Comparison to Conventional Digital Acquisition Systems. Ophthalmic surgery, lasers & imaging retina. 39(4). 304–311. 62 indexed citations

17.

Suñer, Iván J., et al.. (2007). Vision-Related Function After Ranibizumab Treatment by Better- or Worse-Seeing Eye: 24 Month Results From MARINA. Investigative Ophthalmology & Visual Science. 48(13). 1808–1808. 3 indexed citations

18.

Miller, Daniel M., Diego G. Espinosa‐Heidmann, Sander R. Dubovy, et al.. (2004). The association of prior cytomegalovirus infection with neovascular age-related macular degeneration. American Journal of Ophthalmology. 138(3). 323–328. 80 indexed citations

19.

Suñer, Iván J., et al.. (1999). Necrotizing fasciitis after cosmetic blepharoplasty. American Journal of Ophthalmology. 128(3). 367–368. 46 indexed citations

20.

Suñer, Iván J., et al.. (1997). Absent Meibomian Glands in Setleis Syndrome. Journal of Pediatric Ophthalmology & Strabismus. 34(6). 378–380. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact